HTA92 10 Years of AMNOG: Importance of Real-World Evidence Studies in the German Benefit Assessment Process
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1551
https://www.valueinhealthjournal.com/article/S1098-3015(22)03756-1/fulltext
Section Title :
Section Order :
11102
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03756-1&doi=10.1016/j.jval.2022.09.1551